Due to the significant increase in serum levels of IL18 in the patients and the important role of this biomarker in the development of atherosclerosis, IL18 levels should be reduced in patients; also, investigation of IL18 relationship with cardiac complications and cardiac arrhythmias should be examined. Here, IL18 is linked to cardiac arrhythmia.